IJGC Podcast

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Dmitriy Zamarin to discuss immune checkpoint inhibitors in ovarian cancer. Dr. Zamarin is a medical oncologist and a translational research director in gynecologic medical oncology at the Memorial Sloan Kettering Cancer Center. His research focuses on development of novel immune therapeutics in gynecologic mali...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Mario Leitao and Evan Smith to discuss outcomes of low-grade endometrial stromal sarcoma. Dr. Leitao is an attending surgeon and member at Memorial Sloan Kettering Cancer Center as well as a Professor at Weill Cornell Medical College. He serves as the fellowship director at MSKCC as well as the Director of the...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor Bradley J. Monk to discuss the ATHENA-MONO clinical trial. Prof. Monk is an international thought leader and clinical trialist who has developed and advocated for maintenance treatment in newly diagnosed advanced and recurrent ovarian cancer. ATHENA-MONO represents his fifth positive randomized phase 3 tr...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Devon Abt to discuss SLN mapping in endometrial hyperplasia. Devon is a fourth-year Resident in Obstetrics & Gynecology at Beth Israel Deaconess Medical Center/Harvard Medical School currently applying into Gynecologic Oncology fellowship. Highlights: - Fewer than 30% of patients with preoperative diagnosis of endo...

In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ainhoa Madariaga to discuss parp inhibitor treatments and adverse events. Dr. Madariaga's article "Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events" (ijgc.bmj.com/content/early/2020…8/ijgc-2020-001288), was the Lead Article in the July 2020 issue of IJGC....

In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Nicole Concin to discuss the ESGO-ESTRO-ESP Endometrial Cancer Guidelines. Original release date: January 4, 2021

In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Oliver Zivanovic to discuss updates on role of HIPEC in ovarian cancer. Dr. Zivanovic is a Gynecologic Cancer Surgeon at Memorial Sloan Kettering Cancer Center, with the goal to advance the early detection and treatment of women with gynecologic cancers. His special interests include the treatment...

In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Kathleen Schmeler to discuss the ConCerv Trial. Dr. Schmeler is the lead author of “ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer,” which was the Lead Article of IJGC’s October 2021 issue. Dr. Schmeler is a Professor in Gynecologic Oncology at The Un...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor Alejandra Martinez to discuss the Chemotherapy Response Score (CRS) in ovarian cancer. Prof. Martinez has been the Deputy Head of the Surgical Oncology Department at Toulouse University Cancer Center (Institut Universitaire du Cancer de Toulouse) since 2016. She has served as the Director of the ESGO fell...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Robert Coleman and Shannon Westin to discuss updates on overall survival PARP inhibitors. Robert L. Coleman, MD, is a gynecologic oncologist is Houston Texas and serves as SVP and Chief Scientific Officer for US Oncology Research. His primary research interests are in drug development for gynecological cancers...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gillian Hanley to discuss opportunistic salpingectomy for the prevention of ovarian cancer. Gillian Hanley, PhD, is an Associate Professor in the department of Obstetrics & Gynaecology at the University of British Columbia and a Canada Research Chair in Population-based Gynecologic and Perinatal outcomes. She d...

In this episode of the IJGC Podcast, Editorial Fellows Katherine Hicks-Courant and Christina Uwins discuss the contents of the June issue of IJGC.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Mario Preti to discuss the ESGO, ISSVD, ECSVD, and EFC consensus statements on pre-invasive vulvar lesions. Dr. Preti received his Specialization in Gynecology and Obstetrics and Specialization in Medical Oncology at the University of Torino. He is Associate Professor at the Department of Surgical Sciences, Uni...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gerda Trutnovsky to discuss the use of imiquimod versus surgery for the treatment of vHSIL. Dr. Trutnovsky studied at the University of Graz/Austria and the University of Sydney/Australia. She works as an associate professor in the Department of Obstetrics and Gynecology at the Medical University of Graz/Austri...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Dimitrios Nasioudis. Dr. Nasioudis is a Gynecologic Oncology Fellow at the University of Pennsylvania. His current research focuses on translational therapeutics and population-based research. Highlights: The utility of surgical staging for patients with locally advanced cervical cancer has not been established...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Andreas Obermair. Dr. Obermair is a gynecological oncologist in Brisbane, Australia, promoting surgery with proven better patient outcomes. Highlights: - Facing and dealing with adversity in life - Goals for making gynecological oncology safer, less invasive, and smarter; ensuring that patients are not scared o...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Viveros-Carreño. Dr. Viveros-Carreño is a Gynecologic Oncologist at Instituto Nacional de Cancerología, Clínica Universitaria Colombia and Clínica Los Nogales in Bogotá, Colombia. Highlights: - Fertility-sparing surgery after neoadjuvant chemotherapy in cervical cancer >4 cm is feasible, but the evidence...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Katherine Hicks-Courant, MD, MSHP. Dr. Hicks-Courant is a fellow in the Division of Gynecologic Oncology at the University of Pennsylvania. She studies the intersection of gynecologic oncology, palliative care and oncology care delivery systems. Highlights: Having a gynecologic rather than a medical oncologist was...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Rene Pareja to discuss conservative management of cervical cancer. Dr. Pareja is a gynecologist-oncologist at Astorga Oncology Clinic in Medellín and the National Cancer Institute in Bogotá, Colombia. He is a reviewer for more than 20 specialty journals, an Associate Editor for IJGC, a member of the Editorial B...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Susana Banerjee to discuss SOLO1. Dr. Banerjee is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit. She is also Reader in Women’s Cancers at the Institute of Cancer Research. Dr Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers. Highl...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Glauco Baiocchi. Dr. Baiocchi is the Director of the Department of Gynecologic Oncology at the AC Camargo Cancer Center in Sao Paulo, Brazil. Highlights: -SLN biopsy has emerged as an accurate method for lymph node staging in endometrial cancer. -Prospective studies aimed to analyze the performance of SLN biops...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jalid Sehouli. Dr. Sehouli is director of the department of gynecology with center of oncological surgery at Charité Medical University in Berlin. He founded the first certified ovarian cancer center in 2007, published more than 500 articles, and is a teacher and a writer of several belletristic books. Highligh...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Sarah Mah to discuss the gender imbalance in authorship in gynecologic oncology. Sarah Mah is a Gynecologic Oncology fellow at McMaster University who received her MSc in Quality Improvement and Patient Safety through the University of Toronto Institute of Health Policy, Management and Evaluation and completed resi...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Robert Bristow, Prof. Christina Fotopoulou, and Dr. Myong Cheol Lim to discuss Secondary Cytoreductive Surgery in Ovarian Cancer. Dr. Bristow is Professor and Chair of the Department of Obstetrics and Gynecology at the University of California, Irvine School of Medicine. His clinical expertise and research inte...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Supriya Chopra. Dr. Chopra is a Professor in Radiation Oncology at ACTREC, Tata Memorial Centre and Principal Investigator of the PARCER trial. Her research focus is to improve outcomes of cervical cancer through use of advanced radiation techniques in patients undergoing RT for both primary and recurrent metas...